Disappearance of angina pectoris by lipid-lowering in type III hyperlipoproteinemia

Am J Cardiol. 2011 Mar 1;107(5):793-6. doi: 10.1016/j.amjcard.2010.10.063. Epub 2011 Jan 19.

Abstract

Type III hyperlipoproteinemia is a rare familial disease characterized by marked elevations of serum cholesterol and triglyceride levels caused by an accumulation of remnant lipoproteins in apolipoprotein E2/E2 homozygotes. It is associated with an increased risk for premature atherosclerotic vascular disease. A 55-year-old woman was diagnosed as having type III hyperlipoproteinemia on the basis of skin lesions, serum lipid levels, lipid electrophoresis, and apolipoprotein E genotyping and stable angina pectoris on the basis of typical symptoms and treadmill exercise electrocardiographic results. After 1 year of combination therapy with atorvastatin and fenofibrate, skin xanthomata disappeared, leaving minimal remnants. In addition, there was no exertional chest pain, and treadmill exercise electrocardiographic results were negative. This finding was confirmed by coronary computed tomographic angiography. This case suggests that proper medical therapy can induce the regression of uncomplicated coronary lesions in type III hyperlipoproteinemia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angina Pectoris / complications*
  • Angina Pectoris / diagnosis
  • Angina Pectoris / drug therapy
  • Atorvastatin
  • Drug Therapy, Combination
  • Electrocardiography
  • Exercise Test
  • Female
  • Fenofibrate / therapeutic use
  • Follow-Up Studies
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hyperlipoproteinemia Type III / blood
  • Hyperlipoproteinemia Type III / complications
  • Hyperlipoproteinemia Type III / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Middle Aged
  • Pyrroles / therapeutic use
  • Tomography, X-Ray Computed

Substances

  • Heptanoic Acids
  • Hypolipidemic Agents
  • Pyrroles
  • Atorvastatin
  • Fenofibrate